Literature DB >> 14636721

Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles.

C Vauthier1, C Dubernet, C Chauvierre, I Brigger, P Couvreur.   

Abstract

Simultaneous cellular resistance to multiple lipophilic drugs represents a major problem in cancer chemotherapy. This drug resistance may appear clinically either as a lack of tumor size reduction or as the occurrence of clinical relapse after an initial positive response to antitumor treatment. The resistance mechanism can have different origins either directly linked to specific mechanisms developed by the tumor tissue or connected to the more general problem of distribution of a drug towards its targeted tissue. The purpose of this paper is to summarize the results of the use of poly(alkyl cyanoacrylate) nanoparticles to overcome multidrug resistance (MDR) phenomena at both the cellular and the non-cellular level.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14636721     DOI: 10.1016/j.jconrel.2003.08.005

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  39 in total

1.  In vitro evaluation of folic acid modified carboxymethyl chitosan nanoparticles loaded with doxorubicin for targeted delivery.

Authors:  Sumanta K Sahu; Sanjay K Mallick; Susmita Santra; Tapas K Maiti; Sudip K Ghosh; Panchanan Pramanik
Journal:  J Mater Sci Mater Med       Date:  2010-01-29       Impact factor: 3.896

Review 2.  Targeted delivery with peptidomimetic conjugated self-assembled nanoparticles.

Authors:  Esmaiel Jabbari
Journal:  Pharm Res       Date:  2008-12-17       Impact factor: 4.200

3.  In vitro and in vivo imaging of peptide-encapsulated polymer nanoparticles for cancer biomarker activated drug delivery.

Authors:  Gulsim K Kulsharova; Matthew B Lee; Felice Cheng; Munima Haque; Hyungsoo Choi; Kyekyoon Kim; William D O'Brien; G Logan Liu
Journal:  IEEE Trans Nanobioscience       Date:  2013-12       Impact factor: 2.935

4.  Advances of cancer therapy by nanotechnology.

Authors:  Xu Wang; Yiqing Wang; Zhuo Georgia Chen; Dong M Shin
Journal:  Cancer Res Treat       Date:  2009-03-31       Impact factor: 4.679

5.  Characterization of nanoporous surfaces as templates for drug delivery devices.

Authors:  Ashish Rastogi; Tanushree Bose; Marc D Feldman; Devang Patel; Salomon Stavchansky
Journal:  AAPS J       Date:  2009-10-30       Impact factor: 4.009

Review 6.  Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities.

Authors:  Umme Ruman; Sharida Fakurazi; Mas Jaffri Masarudin; Mohd Zobir Hussein
Journal:  Int J Nanomedicine       Date:  2020-03-03

Review 7.  [Nanoparticles as drug delivery systems in ophthalmology].

Authors:  M Löscher; J Hurst; L Strudel; M S Spitzer; S Schnichels
Journal:  Ophthalmologe       Date:  2018-03       Impact factor: 1.059

Review 8.  Nanovehicular intracellular delivery systems.

Authors:  Ales Prokop; Jeffrey M Davidson
Journal:  J Pharm Sci       Date:  2008-09       Impact factor: 3.534

Review 9.  Nanoparticle-based targeted drug delivery.

Authors:  Rajesh Singh; James W Lillard
Journal:  Exp Mol Pathol       Date:  2009-01-07       Impact factor: 3.362

10.  Polybutylcyanoacrylate nanoparticles and drugs of the platinum family: last status.

Authors:  Dashti Rahmat Abadi Fatemeh; Hasan Ebrahimi Shahmabadi; Anita Abedi; Seyed Ebrahim Alavi; Fatemeh Movahedi; Maedeh Koohi Moftakhari Esfahani; Tahereh Zadeh Mehrizi; Azim Akbarzadeh
Journal:  Indian J Clin Biochem       Date:  2013-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.